FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1769450009> ?p ?o ?g. }

• W1769450009 endingPage "1390" @default.
• W1769450009 startingPage "1382" @default.
• W1769450009 abstract "The aim of this study was to assess the cause of enhanced fibrinolysis in cirrhosis by studying the balance between profibrinolytic and antifibrinolytic proteins in 24 patients with mild or severe cirrhosis. Antigen levels of both tissue-type plasminogen activator and plasminogen-activator inhibitor 1 were increased in mild and severe cirrhosis. Activity levels showed a very wide variability, but median activity levels of both proteins were normal. In most patients, the increase in tissue-type plasminogen activator was counterbalanced by the increased levels of plasminogen-activator inhibitor 1, but in a subgroup of patients the change in balance resulted in extremely high tissue-type plasminogen-activator levels. The specific activity of both proteins (activity/antigen quotient) was reduced in either mild or severe cirrhosis. This finding indicates either that more enzyme-inhibitor complexes circulate in the blood of patients with cirrhosis than in normal individuals or that dysfunctional molecules circulate. Plasminogen and alpha 2-antiplasmin antigen and activity levels were decreased in both mild and severe cirrhosis. The binding of alpha 2-antiplasmin to fibrin was decreased in severe cirrhosis, making fibrin clots more susceptible to lysis. Clot lysis experiments were performed to see if equal decreases in plasminogen and alpha 2-antiplasmin levels, as found in cirrhosis, result in a change in the rate of fibrinolysis. It was found that the proportionate decreases led to enhancement of fibrinolysis, indicating that the inhibitor depletion is more important than the proenzyme depletion. The authors conclude that enhanced fibrinolysis frequently found in cirrhosis may be attributed to an increased tissue-type plasminogen-activator activity relative to plasminogen-activator-inhibitor activity and decreased levels of alpha 2-antiplasmin, resulting in a reduced binding of alpha 2-antiplasmin to fibrin." @default.
• W1769450009 created "2016-06-24" @default.
• W1769450009 creator A5002870795 @default.
• W1769450009 creator A5023235480 @default.
• W1769450009 creator A5026525883 @default.
• W1769450009 creator A5037914796 @default.
• W1769450009 creator A5050757013 @default.
• W1769450009 date "1991-11-01" @default.
• W1769450009 modified "2023-10-18" @default.
• W1769450009 title "A shift in balance between profibrinolytic and antifibrinolytic factors causes enhanced fibrinolysis in cirrhosis" @default.
• W1769450009 cites W1965249824 @default.
• W1769450009 cites W1968237857 @default.
• W1769450009 cites W1968376007 @default.
• W1769450009 cites W1968477276 @default.
• W1769450009 cites W1970703245 @default.
• W1769450009 cites W1990986783 @default.
• W1769450009 cites W1992243559 @default.
• W1769450009 cites W2004931531 @default.
• W1769450009 cites W2012839797 @default.
• W1769450009 cites W2013826141 @default.
• W1769450009 cites W2014783250 @default.
• W1769450009 cites W2016872608 @default.
• W1769450009 cites W2023128452 @default.
• W1769450009 cites W2054500561 @default.
• W1769450009 cites W2060123467 @default.
• W1769450009 cites W2062836380 @default.
• W1769450009 cites W2073748704 @default.
• W1769450009 cites W2080328334 @default.
• W1769450009 cites W2094341469 @default.
• W1769450009 cites W2102309294 @default.
• W1769450009 cites W2110780336 @default.
• W1769450009 cites W2144895900 @default.
• W1769450009 cites W2160390803 @default.
• W1769450009 cites W2410006033 @default.
• W1769450009 cites W2410844905 @default.
• W1769450009 cites W2411172952 @default.
• W1769450009 cites W2414492868 @default.
• W1769450009 cites W2415114669 @default.
• W1769450009 cites W2417654761 @default.
• W1769450009 cites W2426848337 @default.
• W1769450009 cites W2440988955 @default.
• W1769450009 cites W2471394735 @default.
• W1769450009 cites W4244633958 @default.
• W1769450009 cites W4254013945 @default.
• W1769450009 cites W76744835 @default.
• W1769450009 doi "https://doi.org/10.1016/0016-5085(91)90092-y" @default.
• W1769450009 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/1718809" @default.
• W1769450009 hasPublicationYear "1991" @default.
• W1769450009 type Work @default.
• W1769450009 sameAs 1769450009 @default.
• W1769450009 citedByCount "108" @default.
• W1769450009 countsByYear W17694500092012 @default.
• W1769450009 countsByYear W17694500092013 @default.
• W1769450009 countsByYear W17694500092014 @default.
• W1769450009 countsByYear W17694500092015 @default.
• W1769450009 countsByYear W17694500092016 @default.
• W1769450009 countsByYear W17694500092017 @default.
• W1769450009 countsByYear W17694500092018 @default.
• W1769450009 countsByYear W17694500092019 @default.
• W1769450009 countsByYear W17694500092020 @default.
• W1769450009 countsByYear W17694500092021 @default.
• W1769450009 countsByYear W17694500092022 @default.
• W1769450009 countsByYear W17694500092023 @default.
• W1769450009 crossrefType "journal-article" @default.
• W1769450009 hasAuthorship W1769450009A5002870795 @default.
• W1769450009 hasAuthorship W1769450009A5023235480 @default.
• W1769450009 hasAuthorship W1769450009A5026525883 @default.
• W1769450009 hasAuthorship W1769450009A5037914796 @default.
• W1769450009 hasAuthorship W1769450009A5050757013 @default.
• W1769450009 hasConcept C126322002 @default.
• W1769450009 hasConcept C134018914 @default.
• W1769450009 hasConcept C141071460 @default.
• W1769450009 hasConcept C185592680 @default.
• W1769450009 hasConcept C203014093 @default.
• W1769450009 hasConcept C2776572282 @default.
• W1769450009 hasConcept C2776825266 @default.
• W1769450009 hasConcept C2777214474 @default.
• W1769450009 hasConcept C2779637338 @default.
• W1769450009 hasConcept C2779679481 @default.
• W1769450009 hasConcept C2781436528 @default.
• W1769450009 hasConcept C2991743468 @default.
• W1769450009 hasConcept C54173615 @default.
• W1769450009 hasConcept C71924100 @default.
• W1769450009 hasConceptScore W1769450009C126322002 @default.
• W1769450009 hasConceptScore W1769450009C134018914 @default.
• W1769450009 hasConceptScore W1769450009C141071460 @default.
• W1769450009 hasConceptScore W1769450009C185592680 @default.
• W1769450009 hasConceptScore W1769450009C203014093 @default.
• W1769450009 hasConceptScore W1769450009C2776572282 @default.
• W1769450009 hasConceptScore W1769450009C2776825266 @default.
• W1769450009 hasConceptScore W1769450009C2777214474 @default.
• W1769450009 hasConceptScore W1769450009C2779637338 @default.
• W1769450009 hasConceptScore W1769450009C2779679481 @default.
• W1769450009 hasConceptScore W1769450009C2781436528 @default.
• W1769450009 hasConceptScore W1769450009C2991743468 @default.
• W1769450009 hasConceptScore W1769450009C54173615 @default.
• W1769450009 hasConceptScore W1769450009C71924100 @default.
• W1769450009 hasIssue "5" @default.

• next